Beneke M, Wingender W, Horstmann R, Konrad-Dalhoff I, Weber H, Kuhlmann J, Schmidt B H
Troponwerke, Cologne, FRG.
Eur J Clin Pharmacol. 1992;42(2):163-9. doi: 10.1007/BF00278478.
The neuroendocrine effects (changes in plasma CRF, ACTH and cortisol) of single and multiple (t.d.s. for 2 days) doses of ipsapirone (BAY Q 7821) 5 and 10 mg have been investigated in 6 healthy male volunteers. The study followed a balanced complete block, placebo-controlled and double blind design with two baseline phases (pre and post-treatment). Volunteers were investigated on identical days during 5 successive weeks. The results do not show a specific effect of ipsapirone on the hypothalamic-pituitary-adrenal axis when doses in the range of 5-30 mg per day were given.